Specific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosis

European Journal of Neurology

Volumn 18, Issue 8, 2011, Pages 1101-1104

  Grau Lopez L ^a   Raich D ^b   Ramo Tello, C ^a   Naranjo Gomez M ^b   Davalos A ^a   Pujol Borrell, R ^b   Borras F E ^b   Martinez Caceres E ^b  

^a Department of Cellular Biology Physiology and Immunology   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Multiple sclerosis; Myelin peptides; T cell proliferation

Indexed keywords

MYELIN; PEPTIDE DERIVATIVE;

ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMYELINATING DISEASE; DISABILITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE;

ADULT; ANTIGENIC MODULATION; CELL PROLIFERATION; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN PROTEINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 79960311172     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03307.x     Document Type: Article

References (10)

1. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990; 346: 183-187.
2. Allegretta M, Nicklas JA, Sriram S, Albertini RJ. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990; 247: 718-721.
3. Saez-Torres I, Brieva L, Espejo C, Barrau MA, Montalban X, Martinez-Caceres EM. Specific proliferation towards myelin antigens in patients with multiple sclerosis during a relapse. Autoimmunity 2002; 35: 45-50.
4. Burns J, Bartholomew B, Lobo S. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis. Ann Neurol 1999; 45: 33-39.
5. Scholz C, Patton KT, Anderson DE, Freeman GJ, Hafler DA. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J Immunol 1998; 160: 1532-1538.
6. Bielekova B, Sung MH, Kadom N, Simon R, McFarland H, Martin R. Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis. J Immunol 2004; 172: 3893-3904.
7. Bielekova B, Goodwin B, Richert N, et al. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med 2000; 6: 1167-1175.
8. Grau-López L, Raïch D, Ramo-Tello C, et al. Myelin peptides in multiple sclerosis. Autoimmun Rev 2009; 8: 650-653.
9. Galetta S, Markowitz C, Lee A. Immunomodulatory agents for the treatment of relapsing multiple sclerosis. Arch Intern Med 2002; 162: 2161-2169.
10. Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat Rev Immunol 2007; 7: 665-677.